Owl biomedical Company

Owl biomedical, Inc. develops microchip-based disposable cell sorting technology for cell purification applications. Its technology is also used for basic stem cell and cancer cell research applications, and stem cell sorting for cosmetic and aesthetic markets. Owl biomedical, Inc. was formerly known as J2D BioMedical, Inc. The company was incorporated in 2010 and is based in Santa Barbara, California. As of April 23, 2013, Owl biomedical, Inc. operates as a subsidiary of Miltenyi Biotec GmbH.
Technology: MarketPlace
Industry: P4 Medicine
Headquarters: United States
Founded Date: 2010-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: $4.1M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
info@owlbiomedical.com
Register and Claim Ownership